title: Prognostic significance of race and tumor size in carcinosarcoma of gallbladder: a meta-analysis of 68 cases.
abstract: Carcinosarcoma of gallbladder, also named sarcomatoid carcinoma and spindle cell carcinoma, is a rare neoplasm. Its clinical features and prognostic determinants are still poorly understood due to its rarity. We identified 67 qualified cases in published literatures and 1 in our institution. 52 of them were females and 16 males (F:M=3.25:1). 27 were Japanese patients and the rest were mainly from the United States and Europe. The mean age was 68.8 years (median 68 years, range 45-91 years). The average tumor size was 6.9 cm (median 5 cm, range 1.0-24.0 cm, n=49). Adenocarcinoma was the most common epithelial component (79.2%) and squamous cell carcinoma was the least common (9.4%). Spindle cell type was the most common mesenchymal component (44.6%) and osteoid was the least common (5.4%). The mean survival was 17.5 months (median 5 months, range 0 to 85 months, n=56). The 1-year and 5-year survival rates were 19+/-5% and 16+/-5% (mean+/-SD), respectively. Kaplan Meier survival analysis was conducted to examine the prognostic value of various clinical parameters. We found Japanese patients had longer survival time than non-Japanese ones (mean=19.9 months vs 11.5 months, median=6 vs 4 months, n=27 vs 24, p=0.022). Patients with smaller tumor (<5.0 cm) had longer survival time (in months) than those with larger tumor (mean 26.6 vs 17.7, median 11 vs 5, n=14 vs 27, p=0.028). The presence of gallstone, epithelial and mesenchymal component types, age and sex of the patients were not significant prognostic factors. In summary, race (Japanese vs non-Japanese) and tumor size are important prognostic factors in carcinosarcoma of gallbladder and they may be used for prognostification.
authors.affiliation: Department of Pathology, Mount Sinai School of Medicine, New York, NY, USA.
authors.forename: Lanjing
authors.initials: L
authors.lastname: Zhang
authors.forename: Zheng
authors.initials: Z
authors.lastname: Chen
authors.forename: Mariko
authors.initials: M
authors.lastname: Fukuma
authors.forename: Lisa Y
authors.initials: LY
authors.lastname: Lee
authors.forename: Maoxin
authors.initials: M
authors.lastname: Wu
references.citation: CA Cancer J Clin. 2001 Nov-Dec;51(6):349-64
references.pmid: 11760569
references.citation: Hum Pathol. 1999 Jan;30(1):21-5
references.pmid: 9923922
references.citation: Cancer. 1970 Mar;25(3):535-41
references.pmid: 5416826
references.citation: Exp Mol Pathol. 2006 Feb;80(1):67-71
references.pmid: 15963980
references.citation: Lancet Oncol. 2003 Mar;4(3):167-76
references.pmid: 12623362
references.citation: Cancer Epidemiol Biomarkers Prev. 1998 Apr;7(4):297-301
references.pmid: 9568784
references.citation: J Pathol. 1971 Jun;104(2):145-8
references.pmid: 5286390
references.citation: J Gastroenterol. 2002;37(11):966-71
references.pmid: 12483254
references.citation: Cancer. 1992 Sep 15;70(6):1493-7
references.pmid: 1516000
references.citation: Semin Oncol. 2002 Dec;29(6 Suppl 20):17-22
references.pmid: 12577229
references.citation: Cancer. 1982 Sep 15;50(6):1166-70
references.pmid: 7104957
references.citation: J Hepatobiliary Pancreat Surg. 2006;13(5):468-71
references.pmid: 17013725
references.citation: Semin Diagn Pathol. 1993 May;10(2):176-87
references.pmid: 8367625
references.citation: J Hepatobiliary Pancreat Surg. 2002;9(5):569-75
references.pmid: 12541042
references.citation: Hum Pathol. 1993 Dec;24(12):1298-305
references.pmid: 8276377
references.citation: Mod Pathol. 1999 Aug;12(8):763-9
references.pmid: 10463477
references.citation: Arch Pathol Lab Med. 2003 Oct;127(10):e406-8
references.pmid: 14521442
references.citation: Cancer. 1984 May 15;53(10):2171-7
references.pmid: 6704904
references.citation: J Cancer Res Clin Oncol. 1999 Aug-Sep;125(8-9):439-43
references.pmid: 10480335
references.citation: J Gastrointest Surg. 2007 May;11(5):671-81
references.pmid: 17468929